Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2921
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00960076 | An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes | ||
| NCT00867048 | Strategic Timing of Antiretroviral Treatment | ||
| NCT02693535 | TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer | ||
| NCT00263276 | A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus | ||
| NCT04921176 | Evaluating Quality of Life of AF Patients Following a Bleed | ||
| NCT00646776 | Drug Interaction Study | ||
| NCT04572893 | Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities | ||
| NCT04470778 | Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants | ||
| NCT05655715 | Checkpoint Inhibitors and SBRT for MCRPC | ||
| NCT03528408 | Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma | ||
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT00117962 | Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | ||
| NCT05065762 | Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment | ||
| NCT00651508 | Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT00382460 | Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22) | ||
| NCT04022980 | Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma | ||
| NCT00872976 | Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia | ||
| NCT03749018 | Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma | ||
| NCT00298987 | A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate | ||
| NCT02866383 | Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients | ||
| NCT03340129 | Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) | ||
| NCT06181630 | A Lactation Study in Women Receiving Treatment With Ozanimod | ||
| NCT00289263 | Maintenance Chemotherapy in Metastatic Breast Cancer | ||
| NCT03660072 | Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma | ||
| NCT07422298 | A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants | ||
| NCT02368301 | Expanded Access Treatment Protocol CA204-143 | ||
| NCT00789581 | A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer | ||
| NCT03416244 | A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer | ||
| NCT00203931 | Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer | ||
| NCT00194753 | Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 | ||
| NCT02164812 | Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects | ||
| NCT00716924 | CASTLE (Clopidogrel And Serum Troponin Level Elevation) | ||
| NCT01573351 | Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) | ||
| NCT00000637 | A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children | ||
| NCT03843619 | Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis | ||
| NCT04008992 | An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants | ||
| NCT06487156 | A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT03141177 | A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma | ||
| NCT00457002 | Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness | ||
| NCT00900783 | A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster | ||
| NCT01314222 | Diabetic Peripheral Neuropathic Pain (DPNP) | ||
| NCT02991196 | Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer | ||
| NCT01450761 | Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone | ||
| NCT02393794 | Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) | ||
| NCT00123474 | Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML | ||
| NCT03316586 | A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer | ||
| NCT03197779 | A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects | ||
| NCT07063342 | A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants | ||
| NCT06947941 | A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) | ||
| NCT00726869 | A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies. |
